8th CML-CAB: Lisbon, Portugal, 16 May 2019

On 16 May 2019, the CML Community Advisory Board (CML-CAB), a workgroup of the CML Advocates Network, hosted its 8th meeting to discuss issues of major concern to the CML community.

CML-CAB Members attending the 8th CML-CAB as patient experts:

• Jan Geissler, Germany (CML-CAB chair) 
• Pat Garcia-Gonzalez, USA, The Max Foundation (Co-chair) 
• Giora Sharf, Israel (Europe)
• Jana Pelouchova, Czech Republic (Central and Eastern Europe)
• Mercedes Arteaga, Argentina (representing Latin America)
• Gail Sperling, USA (representing North America)
• Bahija Gouimi, Morocco (representing Africa and Middle East)
• Rita Christensen, Denmark (representing Western Europe)
• Rod Padua, Philippines (representing East Asia and Pacific)
• Felice Bombaci, Italy (representing Western Europe)
• Silvia Castillo De Armas, Guatemala (Latin America)
• Sarunas Narbutas, Lithuania (Central & Eastern Europe, & West Asia)
• Lisa Machado, Canada (North America)
• Yair Bar David, Israel
• Cornelia Borowczak, Germany (Paediatrics)
• Zack Pemberton-Whiteley, United Kingdom (Western Europe)
• Jelena Cugurovic, Serbia (Eastern Europe)
• Parameswaran Puthen, India (East Asia/Pacific)
• Eunice Orekha, Nigeria (Africa)

Plus, the CML Advocates Network team Lidija Pecova and Celia Marin.

CML-CAB with Novartis, 16th May 2019, 14:00 – 18:00

The following topics were discussed during the CML-CAB:

• Research
• Access
• Treatment-free remission (TFR)
• Collaboration, discussion and Next Steps 

Non-confidential minutes of the meeting are available to CML Advocates Network members below:

pdf 8th CMLCAB May 2019 Novartis Minutes Non-confidential (562 KB)